178 related articles for article (PubMed ID: 33864244)
1. A clinical and biological review of keratoacanthoma.
Tisack A; Fotouhi A; Fidai C; Friedman BJ; Ozog D; Veenstra J
Br J Dermatol; 2021 Sep; 185(3):487-498. PubMed ID: 33864244
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Keratoacanthoma from Well-Differentiated Cutaneous Squamous Cell Carcinoma Using Single-Cell Spatial Pathology.
Veenstra J; Ozog D; Loveless I; Adrianto I; Dimitrion P; Subedi K; Friedman BJ; Zhou L; Mi QS
J Invest Dermatol; 2023 Dec; 143(12):2397-2407.e8. PubMed ID: 37419445
[TBL] [Abstract][Full Text] [Related]
3. [Keratoacanthomas on recent tattoos: Two cases].
Kluger N; Douvin D; Dupuis-Fourdan F; Doumecq-Lacoste JM; Descamps V
Ann Dermatol Venereol; 2017 Dec; 144(12):776-783. PubMed ID: 29126557
[TBL] [Abstract][Full Text] [Related]
4. Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma.
Carr RA; Mesiano D; Heffron C; Radonic T; Wiggins J; Tso S; Agrawal R; Cheung E; Slater DN; Nichols L; Craig P
Pathology; 2023 Oct; 55(6):772-784. PubMed ID: 37573161
[TBL] [Abstract][Full Text] [Related]
5. Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma.
Gambichler T; Gnielka M; Rüddel I; Stockfleth E; Stücker M; Schmitz L
Cancer Immunol Immunother; 2017 Sep; 66(9):1199-1204. PubMed ID: 28501937
[TBL] [Abstract][Full Text] [Related]
6. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.
Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E
Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454
[TBL] [Abstract][Full Text] [Related]
7. Keratoacanthoma: Update on the Debate.
Nirenberg A; Steinman H; Dixon A
Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
[TBL] [Abstract][Full Text] [Related]
8. Low detection rate of human papillomavirus in patients with cutaneous squamous cell carcinoma and keratoacanthoma.
Baek YS; Kim YC; Kim KE; Jeon J; Kim A; Song HJ; Kim C
Eur J Dermatol; 2022 Sep; 32(5):577-583. PubMed ID: 36468731
[TBL] [Abstract][Full Text] [Related]
9. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histopathological and immunohistochemical study of keratoacanthoma.
Vîlcea AM; Stoica LE; Georgescu CV; Popescu FC; Ciurea RN; Vîlcea ID; Mirea CS
Rom J Morphol Embryol; 2021; 62(2):445-456. PubMed ID: 35024732
[TBL] [Abstract][Full Text] [Related]
11. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
12. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
13. Computer Image Analysis Reveals C-Myc as a Potential Biomarker for Discriminating between Keratoacanthoma and Cutaneous Squamous Cell Carcinoma.
Fan X; Niu X; Wu Z; Yao L; Chen S; Wan W; Huang B; Qi RQ; Zhang T
Biomed Res Int; 2022; 2022():3168503. PubMed ID: 36051475
[TBL] [Abstract][Full Text] [Related]
14. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
Goldenhersh MA; Olsen TG
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
16. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
17. Keratoacanthoma. A clinical study.
Kingman J; Callen JP
Arch Dermatol; 1984 Jun; 120(6):736-40. PubMed ID: 6721538
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma and keratoacanthomas are biologically distinct and can be diagnosed by light microscopy: a review.
Selmer J; Skov T; Spelman L; Weedon D
Histopathology; 2016 Oct; 69(4):535-41. PubMed ID: 27323251
[TBL] [Abstract][Full Text] [Related]
19. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
[TBL] [Abstract][Full Text] [Related]
20. Keratoacanthoma (KA): An update and review.
Kwiek B; Schwartz RA
J Am Acad Dermatol; 2016 Jun; 74(6):1220-33. PubMed ID: 26853179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]